Validation of the IMPROVE‐DD risk assessment model for venous thromboembolism among hospitalized patients with COVID‐19

Validation of the IMPROVE‐DD risk assessment model for venous thromboembolism among hospitalized patients with COVID‐19

Abstract Background Antithrombotic guidance statements for hospitalized patients with coronavirus disease 2019 (COVID‐19) suggest a universal thromboprophylactic strategy with potential to escalate doses in high‐risk patients. To date, no clear approach exists to discriminate patients at high risk f...

Full description

Bibliographic Details
Main Authors: Alex C. Spyropoulos, Stuart L. Cohen, Eugenia Gianos, Nina Kohn, Dimitrios Giannis, Saurav Chatterjee, Mark Goldin, Marty Lesser, Kevin Coppa, Jamie S. Hirsch, Thomas McGinn, Matthew A. Barish, the COVID‐19 Consortium Group
Format: Article
Language:English
Published: Wiley 2021-02-01
Series:Research and Practice in Thrombosis and Haemostasis
Subjects:
COVID‐19
hospitalized patients
risk assessment
thromboembolism
thrombosis
Online Access:https://doi.org/10.1002/rth2.12486

Internet

https://doi.org/10.1002/rth2.12486

Similar Items